Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
September 2013 Volume 43 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September 2013 Volume 43 Issue 3

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments

  • Authors:
    • Roberto Amendola
    • Manuela Cervelli
    • Emiliano Fratini
    • Davide E. Sallustio
    • Giampiero Tempera
    • Taichi Ueshima
    • Paolo Mariottini
    • Enzo Agostinelli
  • View Affiliations / Copyright

    Affiliations: ENEA, CR Casaccia, UT Bio-Rad RAB, I-00123 Rome, Italy, Department of Biology, University of ‘Roma Tre’, I-00146 Rome, Italy, Institute Pasteur Cenci-Bolognetti Foundation and Department of Biochemical Sciences ‘A. Rossi Fanelli’, University of Rome ‘Sapienza’ and CNR, Biology and Molecular Pathology Institutes, I-00185 Rome, Italy
  • Pages: 813-820
    |
    Published online on: July 12, 2013
       https://doi.org/10.3892/ijo.2013.2013
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The most frequent interventions in cancer therapy are currently the destruction of cells by irradiation or administration of drugs both able to induce radical formation and toxic metabolites by enzyme-catalyzed reactions. The aim of this study was to determine the cell viability of cells undergoing a DNA damage threshold accomplished by ROS overproduction via both ectopic expression of murine spermine oxidase (mSMOX) and bovine serum amine oxidase (BSAO) enzymes. Low dose of X-irradiation delivers a challenging dose of damage as evaluated in proficient Chinese hamster AA8 cell line and both deficient transcription-coupled nucleotide excision repair (NER) UV61 cells and deficient base excision repair (BER) EM9 cells, at 6 and 24 h after exposure. The priming dose of ROS overexposure by mSMOX provokes an adaptive response in N18TG2, AA8 and EM9 cell lines at 24 h. Interestingly, in the UV61 cells, ROS overexposure by mSMOX delivers an earlier adaptive response to radiation. The enzymatic formation of toxic metabolites has mainly been investigated on wild-type (WT) and multidrug-resistant (MDR) cancer cell lines, using and spermine as substrate of the BSAO enzyme. MDR cells are more sensitive to the toxic polyamine metabolites than WT cells, thus indicating a new therapeutic strategy to overcome MDR tumors. Since SMOX in mammals is differentially activated in a tissue-specific manner and cancer cells can differ in terms of DNA repair and MDR capabilities, it could be of interest to simultaneously treat with very low dose of X-rays and/or to alter SMOX metabolism to generate a differential response in healthy and cancer tissues.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Ames BN, Shigenaga MK and Hagen TM: Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA. 90:7915–7922. 1993. View Article : Google Scholar : PubMed/NCBI

2 

Chance B, Sies H and Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev. 59:527–605. 1979.PubMed/NCBI

3 

Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Ghavami S, Eshragi M, Ande SR, et al: S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 20:314–331. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T and Pervaiz S: Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One. 5:e99962010. View Article : Google Scholar : PubMed/NCBI

6 

Kamata H, Honda S, Maeda S, et al: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 120:649–661. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Wallace HM, Fraser AV and Hughes A: A perspective of polyamine metabolism. Biochem J. 376:1–14. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Casero RA Jr and Marton LJ: Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov. 6:373–390. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Ploszaj T, Motyl T, Zimowska W, Skierski J and Zwierzchowski L: Inhibition of ornithine decarboxylase by α-difluoromethylornithine induces apoptosis in HC11 mouse mammary epithelial cells. Amino Acids. 19:483–496. 2000.

10 

Seiler N and Raul F: Polyamines and apoptosis. J Cell Mol Med. 9:623–642. 2005. View Article : Google Scholar

11 

Amendola R, Cervelli M, Fratini E, Polticelli F, Sallustio DE and Mariottini P: Spermine metabolism and anticancer therapy. Cur Cancer Drug Targets. 9:118–130. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Calcabrini A, Arancia G, Marra M, et al: Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts. Int J Cancer. 99:43–52. 2002. View Article : Google Scholar

13 

Arancia G, Calcabrini A, Marra M, et al: Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells. Amino Acids. 26:273–282. 2004. View Article : Google Scholar

14 

Pledgie A, Huang Y, Hacker A, et al: Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analog-treated human breast cancer cell lines. J Biol Chem. 280:39843–39851. 2005.PubMed/NCBI

15 

Bianchi M, Bellini A, Cervelli M, et al: Chronic sub-lethal oxidative stress by spermine oxidase over activity induces continuous DNA repair and hypersensitivity to radiation exposure. Biochim Biophys Acta. 1773:774–783. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Amendola R, Bellini A, Cervelli M, et al: Direct oxidative DNA damage, apoptosis and radio sensitivity by spermine oxidase activities in mouse neuroblastoma cells. Biochim Biophys Acta Rev Cancer. 1775:15–24. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Agostinelli E, Arancia G, Dalla Vedova L, et al: The biological functions of polyamine oxidation products by amine oxidises: perspectives of clinical applications. Amino Acids. 27:347–358. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Agostinelli E, Dalla Vedova L, Belli F, Condello M, Arancia G and Seiler N: Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by lysosomotropic compounds. Int J Oncol. 29:947–955. 2006.PubMed/NCBI

19 

Agostinelli E, Condello M, Molinari A, Tempera G, Viceconte N and Arancia G: Cytotoxicity of spermine oxidation products to multidrug resistant melanoma cells (M14 ADR2): sensitisation by MDL 72527, a lysosomotropic compound. Int J Oncol. 35:485–498. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Soares FA, Shaugnessy SG, MacLarkey WR and Orr FW: Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo. Lab Invest. 71:480–489. 1994.PubMed/NCBI

21 

Thompson LH, Brookman KW, Dillehay LE, et al: A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair and an extraordinary baseline frequency of sister-chromatid exchange. Mutat Res. 95:427–440. 1982. View Article : Google Scholar : PubMed/NCBI

22 

Thompson LH, Salazar EP, Brookman KW, et al: Recent progress with the DNA repair mutants of Chinese hamster ovary cells. J Cell Sci. (Suppl 6): 97–110. 1987. View Article : Google Scholar : PubMed/NCBI

23 

Pelicano H, Carney D and Huang P: ROS stress in cancer cells and therapeutic implication. Drug Resist Updat. 7:97–110. 2004. View Article : Google Scholar

24 

Grandi M, Geroni C and Giuliani FC: Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. Br J Cancer. 54:515–518. 1986. View Article : Google Scholar : PubMed/NCBI

25 

Turini P, Sabatini S, Befani O, et al: Purification of serum amine oxidase. Anal Biochem. 125:294–298. 1982. View Article : Google Scholar

26 

Bahn S, Mimmack M, Ryan M, et al: Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down’s syndrome: a gene expression study. Lancet. 359:310–315. 2002.PubMed/NCBI

27 

Sharmin S, Sakata K, Kashiwagi K, et al: Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun. 282:228–235. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Regulus P, Duroux B, Bayle PA, et al: Oxidation of the sugar moiety of DNA by ionizing radiation or bleomycin could induce the formation of a cluster DNA lesion. Proc Natl Acad Sci USA. 104:14032–14037. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Eccles LJ, Lomax ME and O’Neill P: Hierarchy of lesion processing governs the repair, double-strand break formation and mutability of three-lesion clustered DNA damage. Nucleic Acids Res. 38:1123–1134. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Hitomi K, Iwai S and Tainer JA: The intricate structural chemistry of base excision repair machinery: implications for DNA damage recognition, removal and repair. DNA Repair. 6:410–428. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Zharkov DO: Base excision DNA repair. Cell Mol Life Sci. 65:1544–1565. 2008. View Article : Google Scholar

32 

Maxwell CA, Fleisch MC, Sylvain V, et al: Targeted and nontargeted effects of ionizing radiation that impact genomic instability. Cancer Res. 68:8304–8831. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Agostinelli E, Belli F, Molinari A, et al: Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitization by heat and MDL 72527. Biochim Biophys Acta. 1763:1040–1050. 2006. View Article : Google Scholar : PubMed/NCBI

34 

Agostinelli E and Seiler N: Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (Review). Int J Oncol. 31:473–484. 2007.PubMed/NCBI

35 

Agostinelli E and Seiler N: Non-irradiation-derived reactive oxygen species (ROS) and cancer. Therapeutic implications. Amino Acids. 31:341–355. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Amendola R, Cervelli M, Fratini E, Sallustio DE, Tempera G, Ueshima T, Mariottini P and Agostinelli E: Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. Int J Oncol 43: 813-820, 2013.
APA
Amendola, R., Cervelli, M., Fratini, E., Sallustio, D.E., Tempera, G., Ueshima, T. ... Agostinelli, E. (2013). Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. International Journal of Oncology, 43, 813-820. https://doi.org/10.3892/ijo.2013.2013
MLA
Amendola, R., Cervelli, M., Fratini, E., Sallustio, D. E., Tempera, G., Ueshima, T., Mariottini, P., Agostinelli, E."Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments". International Journal of Oncology 43.3 (2013): 813-820.
Chicago
Amendola, R., Cervelli, M., Fratini, E., Sallustio, D. E., Tempera, G., Ueshima, T., Mariottini, P., Agostinelli, E."Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments". International Journal of Oncology 43, no. 3 (2013): 813-820. https://doi.org/10.3892/ijo.2013.2013
Copy and paste a formatted citation
x
Spandidos Publications style
Amendola R, Cervelli M, Fratini E, Sallustio DE, Tempera G, Ueshima T, Mariottini P and Agostinelli E: Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. Int J Oncol 43: 813-820, 2013.
APA
Amendola, R., Cervelli, M., Fratini, E., Sallustio, D.E., Tempera, G., Ueshima, T. ... Agostinelli, E. (2013). Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. International Journal of Oncology, 43, 813-820. https://doi.org/10.3892/ijo.2013.2013
MLA
Amendola, R., Cervelli, M., Fratini, E., Sallustio, D. E., Tempera, G., Ueshima, T., Mariottini, P., Agostinelli, E."Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments". International Journal of Oncology 43.3 (2013): 813-820.
Chicago
Amendola, R., Cervelli, M., Fratini, E., Sallustio, D. E., Tempera, G., Ueshima, T., Mariottini, P., Agostinelli, E."Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments". International Journal of Oncology 43, no. 3 (2013): 813-820. https://doi.org/10.3892/ijo.2013.2013
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team